
WYE-125132
CAS No. 1144068-46-1
WYE-125132( WYE-132 | WYE125132 )
Catalog No. M10513 CAS No. 1144068-46-1
A potent, specific, ATP-competitive and orally active mTOR inhibitor with IC50 of 0.19 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 247 | In Stock |
![]() ![]() |
50MG | 847 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameWYE-125132
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, specific, ATP-competitive and orally active mTOR inhibitor with IC50 of 0.19 nM.
-
DescriptionA potent, specific, ATP-competitive and orally active mTOR inhibitor with IC50 of 0.19 nM; dispalys high selectivity (>5,000-fold) over PI3Ks, the PI3K-related kinases hSMG1 and ATR, and a panel of 230 protein kinases; inhibits mTORC1-dependent phosphorylation of S6K(T389) and mTORC2-dependent phosphorylation of AKT(S473), inhibits cancer cell proliferation, cell cycle progression, and induces apoptosis; shows potent single-agent antitumor activity against multiple cancer models.
-
In Vitro——
-
In Vivo——
-
SynonymsWYE-132 | WYE125132
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptormTOR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1144068-46-1
-
Formula Weight519.5954
-
Molecular FormulaC27H33N7O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 62 mg/mL
-
SMILESO=C(NC)NC1=CC=C(C2=NC(N3CC(O4)CCC4C3)=C5C(N(C(CC6)CCC76OCCO7)N=C5)=N2)C=C1
-
Chemical NameUrea, N-[4-[1-(1,4-dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yu K, et al. Cancer Res. 2010 Jan 15;70(2):621-31.
molnova catalog



related products
-
RapaLink-1
RapaLink-1 is a third-generation mTOR inhibitor that overcomes resistance to existing first- and second-generation inhibitors.
-
NSC781406
NSC781406 is a highly effective inhibitor of PI3K and mTOR (IC50: 2 nM for PI3Kα).
-
Seco Rapamycin
Seco-rapamycin is the first in vivo open-ring metabolite of rapamycin that does not affect mTOR.